PPARG and metabolic dysfunction-associated steatotic liver disease: These results suggest that differential regulation of liver proteasome transcription and PPARG expression and ubiquitination may at least partly account for resistance (BALB/c) and susceptibility (C57BL/6J) to HFD-induced NAFLD.